阅读说明：本技术 氧胶囊、其制备方法与应用 (Oxygen capsule, preparation method and application thereof ) 是由 余孟春 余咏 于 2021-10-19 设计创作，主要内容包括：本发明公开一种氧胶囊及其制备方法与应用。本发明提供的氧胶囊的制备方法包括如下步骤：对脱臭可可脂进行三级分离,然后将负氧离子与经过三级分离后的脱臭可可脂液体进行混合处理,将离子氧存储在脱臭可可脂液体中,最后将经负氧离子处理过的脱臭可可脂液体灌装进胶囊壳中制成胶囊剂,从而制得氧胶囊。本发明提供的氧胶囊含氧量高,具有良好的补氧效果,对高血压、痛风、胃溃疡、焦虑症等多种慢性非传染性疾病以及系统性红斑狼疮、高原反应等均具有良好的预防、治疗或者辅助治疗的效果。(The invention discloses an oxygen capsule and a preparation method and application thereof. The preparation method of the oxygen capsule provided by the invention comprises the following steps: performing three-stage separation on the deodorized cocoa butter, mixing negative oxygen ions with the deodorized cocoa butter liquid subjected to the three-stage separation, storing the ionic oxygen in the deodorized cocoa butter liquid, and finally filling the deodorized cocoa butter liquid subjected to the negative oxygen ion treatment into capsule shells to prepare capsules, thereby preparing the oxygen capsules. The oxygen capsule provided by the invention has high oxygen content and good oxygen supplementing effect, and has good effects of preventing, treating or assisting in treating various chronic non-infectious diseases such as hypertension, gout, gastric ulcer, anxiety and the like, systemic lupus erythematosus, altitude stress and the like.)

1. The preparation method of the oxygen capsule is characterized by comprising the following steps:

(1) heating deodorized cacao butter to 50-70 deg.C, cooling to 25-28 deg.C, standing at 25-28 deg.C for a certain time, filtering, and collecting cacao butter liquid A;

(2) heating cocoa butter liquid A to 30-33 deg.C, cooling to 19-21 deg.C, standing at 19-21 deg.C for a certain time, filtering, and collecting cocoa butter liquid B;

(3) stirring the cocoa butter liquid B at 15-18 deg.C for a certain time, filtering, and collecting the liquid to obtain cocoa butter liquid C;

(4) placing the cocoa butter liquid C in a mixing device, conveying negative oxygen ions into the mixing device to be mixed with the cocoa butter liquid C, and stopping conveying the negative oxygen ions when the mixing of the negative oxygen ions and the cocoa butter liquid C reaches a saturated state to obtain the content of the oxygen capsule;

(5) and filling the content of the oxygen capsule into a capsule shell to obtain the oxygen capsule.

2. The method according to claim 1, wherein the capsule shell is at least one selected from the group consisting of gelatin capsule shell, glutinous rice capsule shell, and corn capsule shell.

3. The method of claim 2, wherein the capsule shell is a gelatin capsule shell.

4. The method of claim 3, comprising the steps of:

(1) heating deodorized cacao butter to 50-70 deg.C, cooling to 25-28 deg.C, standing at 25-28 deg.C for 5-7 min, filtering, and collecting cacao butter liquid A;

(2) heating cocoa butter liquid A to 30-33 deg.C, cooling to 20 deg.C, standing at 20 deg.C for 6-8 min, filtering, and collecting cocoa butter liquid B;

(3) stirring the cocoa butter liquid B at 15-18 deg.C for 6-8 min, filtering, and collecting the liquid to obtain cocoa butter liquid C;

(4) placing the cocoa butter liquid C in a mixing tank, then conveying negative oxygen ions into the mixing tank to be mixed with the cocoa butter liquid C, and stopping conveying the negative oxygen ions when the mixing of the negative oxygen ions and the cocoa butter liquid C reaches a saturated state to obtain the content of the oxygen capsule;

(5) and filling the content of the oxygen capsule into a gelatin capsule shell to obtain the oxygen capsule.

5. The method according to any one of claims 1 to 4, wherein the oxygen capsule content has an oxygen content of 10 to 30% by mass.

6. An oxygen capsule produced by the production method according to any one of claims 1 to 5.

7. The use of the oxygen capsule of claim 6 in the preparation of a medicament or health food for the prevention or adjuvant treatment of chronic non-infectious diseases.

8. The use of claim 7, wherein the chronic non-infectious disease is at least one of hypertension, gout, chronic prostatitis, gastric ulcer, anxiety, and senile dementia.

9. The use of the oxygen capsule of claim 6 in the preparation of a medicament or health food for the prevention or adjuvant treatment of systemic lupus erythematosus.

10. The use of the oxygen capsule of claim 6 in the preparation of a medicament or health food for the prevention or adjuvant treatment of altitude sickness.

Technical Field

The invention belongs to the technical field of medicines, and particularly relates to an oxygen capsule as well as a preparation method and application thereof.

Background

The three elements of human cell survival are water, nutrition (including protein, fat, carbohydrate, mineral substances and trace elements) and oxygen, mild hypoxia can accelerate the heartbeat, rapid respiration and seriously endanger the life of a human, and researches show that irreversible death can occur when brain tissue cells are anoxic for a plurality of minutes. Most of bacteria, viruses and cancer cells harmful to human body are more active under hypoxic condition, and hypoxia is a significant factor of various diseases such as cancer, immune and degenerative diseases. The physiological and medical nobel prize of 2019 was awarded to three scientists who studied the mechanism of human oxygen perception and they concluded that Hypoxia Inducible Factor (HIF) is a transcription factor for hypoxia-related genes. HIF accumulation in cells can induce tumor vascular growth. Therefore, the oxygen supplement has direct promotion effect on human health, and can effectively improve the immunity and the self-healing capability of the human body.

The main pathway for oxygen absorption in the human body is through respiration, via the alveoli, by molecular oxygen (O)₂) Reacts with iron in hemoglobin, converts into ion oxygen (O), and supplies oxygen to organs of the whole body through a blood circulation system. In order to save the lives of patients or keep healthy and old people, people continuously explore various methods for artificial oxygen supplementation, and oxygen inhalation and insertion are commonly usedTubes, ventilators, hyperbaric oxygen chambers, and the like. However, these methods all require gas exchange through the lung of human body, and when the oxygen supply channel is obstructed, such as acute pneumonia, inhalation injury caused by pulmonary edema and burn, and respiratory failure caused by brain injury, etc., these conventional methods for supplying oxygen to respiratory tract are not effective, and the life of the patient is greatly damaged. Opening a new oxygen supply channel becomes a research hotspot and difficulty in the medical field.

Researchers at the us boston children hospital injected oxygenated microparticles into trachea-occluded rabbits to allow them to survive 15 minutes in a non-respiratory state and maintain normal blood pressure and heart rate. The oxygenated microparticles are a microparticle capsule containing a layer of globules of lipid biomolecules, each surrounded by small bubbles of oxygen, which are injected into the blood mainly by injection (see ssv wei. oxygenated microparticles which allow 15 min survival in rabbits with stopped breathing [ N ] scientific diary 2012-06-29(001) ]).

In order to overcome the limitation of oxygen supplementing modes of a breathing machine, a hyperbaric oxygen chamber and the like, people also invent a negative oxygen ion generating device, such as the negative oxygen ion generating device disclosed in Chinese patent CN 108539592B. If the human body can directly absorb a large amount of negative oxygen ions generated by the negative oxygen ion generating device, the bottleneck that the current oxygen supply method is limited by the alveolar transformation capability of the human body can be broken through. However, oxygen ions (O) are extremely unstable substances, and in air, oxygen (O) is easily formed by bonding₂) And superoxide (O)₃). If negative oxygen ions generated by the negative oxygen ion generating device are released into the air, almost no oxygen ions are detected at a place where the negative oxygen ion release opening is deviated by several centimeters. Therefore, the oxygen ions released from the negative oxygen ion generating device can be absorbed by the human body, and are very limited, so that the oxygen ions have great limitations in the aspects of absorption and effective utilization of high enough concentration by the human body, remarkable rehabilitation and curative effect and the like.

Disclosure of Invention

The invention aims to provide a preparation method of an oxygen capsule, which comprises the steps of treating deodorized cocoa butter liquid subjected to three-stage separation by using negative oxygen ions generated by a negative oxygen ion generator, storing ionic oxygen in the deodorized cocoa butter liquid, and filling the deodorized cocoa butter liquid stored with the ionic oxygen and subjected to the negative oxygen ion treatment into a capsule shell to prepare the capsule, thereby obtaining the oxygen capsule. The oxygen capsule provided by the invention has high oxygen content and good oxygen supplementing effect, and is specifically represented as follows: has good prevention and treatment or adjuvant treatment effects on various chronic non-infectious diseases such as hypertension, gout, gastric ulcer, anxiety and the like, systemic lupus erythematosus, altitude stress and the like.

Another object of the present invention is to provide the use of the oxygen capsule in the preparation of a medicament or health food for the prevention, treatment or adjuvant treatment of at least one of chronic non-infectious diseases, systemic lupus erythematosus, altitude sickness.

According to an aspect of the present invention, there is provided a method for preparing an oxygen capsule, comprising the steps of:

(1) heating deodorized cacao butter to 50-70 deg.C, cooling to 25-28 deg.C, standing at 25-28 deg.C for a certain time, filtering, and collecting cacao butter liquid A;

(2) heating cocoa butter liquid A to 30-33 deg.C, cooling to 19-21 deg.C, standing at 19-21 deg.C for a certain time, filtering, and collecting cocoa butter liquid B;

(3) stirring the cocoa butter liquid B at 15-18 deg.C for a certain time, filtering, and collecting the liquid to obtain cocoa butter liquid C;

(4) placing the cocoa butter liquid C in a mixing device, conveying negative oxygen ions into the mixing device to be mixed with the cocoa butter liquid C, and stopping conveying the negative oxygen ions when the mixing of the negative oxygen ions and the cocoa butter liquid C reaches a saturated state to obtain deodorized cocoa butter liquid treated by the negative oxygen ions, namely oxygen capsule content;

(5) and filling the content of the oxygen capsule into a capsule shell to obtain the oxygen capsule.

Compared with solid cocoa butter, liquid cocoa butter is easier to mix with and chemically react with negative oxygen ions, the negative oxygen ions are fully absorbed and converted into oxygen ions to be stored in the cocoa butter, and oxygen capsules prepared by using cocoa butter liquid with a single crystal structure or a crystal structure which tends to be single have higher oxygen content. Cocoa butter has a polycrystalline character and cocoa butter in different crystal forms has different melting points, and therefore, by utilizing this characteristic of cocoa butter, it is possible to perform multistage separation to obtain cocoa butter having a single crystal structure or substantially a single crystal structure. According to the invention, after cocoa butter liquid C obtained by three-stage separation of deodorized cocoa butter is mixed with negative oxygen ions and undergoes chemical reaction, the oxygen content of the deodorized cocoa butter liquid (namely oxygen capsule content) treated by the negative oxygen ions can reach 10-30% by mass percent.

At 5 ℃ or below, the oxygen ions contained in the contents of the oxygen capsule are substantially in a stable state. As the temperature increases, oxygen ions begin to be released gradually, with the rate of release being faster at higher temperatures. Oxygen ions contained in the oxygen capsule content are in a semi-stable state at normal temperature, so the oxygen capsule provided by the invention needs to be placed in a refrigerator for refrigeration and preservation.

The oxygen capsule provided by the invention can be taken with water. After the oxygen capsule enters the stomach and intestine of a human body, under the action of the body temperature of the human body, oxygen ions in the content of the oxygen capsule start to be released, are absorbed by the mucous membrane of the stomach and intestine, enter a circulatory system and are delivered to organs of various parts of the body.

In the present application, the capsule shell used for preparing the oxygen capsule may be any one of the pharmaceutical grade or food grade capsule shells disclosed in the prior art, and in some embodiments, the capsule shell may be selected from at least one of food grade or pharmaceutical grade gelatin capsule shells, glutinous rice capsules, and corn capsules.

In some embodiments, the capsule shell can be a pharmaceutical grade gelatin capsule shell.

As one of more preferred embodiments, the method for preparing the oxygen capsule may include the steps of:

(1) heating deodorized cacao butter to 50-70 deg.C, cooling to 25-28 deg.C, standing at 25-28 deg.C for 5-7 min, filtering, and collecting cacao butter liquid A;

(2) heating cocoa butter liquid A to 30-33 deg.C, cooling to 20 deg.C, standing at 20 deg.C for 6-8 min, filtering, and collecting cocoa butter liquid B;

(3) stirring the cocoa butter liquid B at 15-18 deg.C for 6-8 min, filtering, and collecting the liquid to obtain cocoa butter liquid C;

(4) placing the cocoa butter liquid C in a mixing tank, then conveying negative oxygen ions into the mixing tank to be mixed with the cocoa butter liquid C, and stopping conveying the negative oxygen ions when the mixing of the negative oxygen ions and the cocoa butter liquid C reaches a saturated state to obtain the content of the oxygen capsule;

(5) and filling the content of the oxygen capsule into a gelatin capsule shell to obtain the oxygen capsule.

In the present invention, since the negative oxygen ions are transferred to the mixing tank and mixed with the cocoa butter liquid C, the negative oxygen ions and the cocoa butter liquid C undergo an oxidation reaction, which is an exothermic reaction, and thus, the temperature of the mixture and the mixing tank is increased to be higher than the ambient temperature, and therefore, in the process of transferring the negative oxygen ions into the cocoa butter liquid C, whether the mixture of the negative oxygen ions and the cocoa butter liquid C has reached a saturated state can be judged by judging whether the temperature of the mixture and/or the mixing tank is again or substantially equal to the ambient temperature.

The early trial tests prove that the oxygen capsule provided by the invention can be effectively used for treating or assisting in treating chronic non-infectious diseases such as hypertension, gout, chronic prostatitis, gastric ulcer, anxiety, senile dementia and the like, and systemic lupus erythematosus, altitude reaction and the like, so that according to another aspect of the invention, the oxygen capsule is provided for preparing a medicine or health-care food for preventing, treating or assisting in treating at least one of chronic non-infectious diseases, systemic lupus erythematosus and altitude reaction.

Compared with the prior art, the invention has the beneficial effects that:

(1) the preparation method of the oxygen capsule provided by the invention has the advantages of simple process, easy operation and implementation and wide raw material source;

(2) in the preparation process of the oxygen capsule provided by the invention, only two components of deodorized cocoa butter and negative oxygen ions and a food-grade or medical-grade capsule shell are used as raw materials, the components are safe, and the oxygen capsule is convenient to carry and take, so that when the oxygen capsule is used for treating diseases or assisting in treating the diseases, the medication compliance of a user is high;

(3) the oxygen capsule provided by the invention has a remarkable oxygen supplementing effect, and has a remarkable treatment or auxiliary treatment effect on chronic non-infectious diseases such as hypertension, gout, chronic prostatitis, gastric ulcer, anxiety, senile dementia and the like, and systemic lupus erythematosus.

Drawings

FIG. 1 is a diagram of an infrared spectrum of the contents of an oxygen capsule of the present invention;

FIG. 2 is a thermal cracking gas chromatography mass spectrometry (Py-GC/MS) total ion flow diagram of the oxygen capsule contents of the present invention;

FIG. 3 is a NMR spectrum of the contents of the oxygen capsule of the present invention;

FIG. 4 is a nuclear magnetic resonance carbon spectrum of the contents of the oxygen capsule of the present invention.

Detailed Description

The present invention will be described in further detail with reference to embodiments. The examples are for illustration only and do not limit the invention in any way. Unless otherwise specified, the starting materials and reagents used in the examples are conventional products commercially available; the experimental methods in the examples, in which specific conditions are not noted, are conventional methods and conventional conditions well known in the art.

EXAMPLE 1 preparation of oxygen capsules

The method comprises the following steps:

(1) heating deodorized cacao butter to about 50 deg.C, continuously stirring to melt deodorized cacao butter, cooling to about 28 deg.C, standing at 25-28 deg.C for about 5 min, filtering, and collecting liquid to obtain cacao butter liquid A;

(2) heating the cocoa butter liquid A to about 33 ℃ while stirring, then placing the cocoa butter liquid A into a constant temperature device with the temperature set to 20 ℃ for standing for 6 minutes, and filtering and collecting the liquid to obtain cocoa butter liquid B;

(3) placing the cocoa butter liquid B in a constant temperature device with the temperature set at 15 ℃, continuously stirring for about 6 minutes, and filtering and collecting the liquid to obtain cocoa butter liquid C;

(4) placing the cocoa butter liquid C in a sealed mixing tank, then conveying negative oxygen ions generated by a negative oxygen ion generating device into the mixing tank through a sealed pipeline, mixing the negative oxygen ions with the cocoa butter liquid C, and stopping conveying the negative oxygen ions when the temperature of the mixing tank is firstly increased and then is reduced to be consistent with or basically consistent with the ambient temperature, namely when the mixing of the negative oxygen ions and the cocoa butter liquid C reaches a saturated state, so as to obtain the content of the oxygen capsule;

(5) filling the content of the oxygen capsule into a pharmaceutical-grade gelatin capsule shell to obtain the oxygen capsule.

EXAMPLE 2 preparation of oxygen capsules

The method comprises the following steps:

(1) heating deodorized cacao butter to about 60 deg.C, continuously stirring to melt deodorized cacao butter, cooling to about 25 deg.C, standing in a constant temperature device set at 25 deg.C for about 7 min, filtering, and collecting liquid to obtain cacao butter liquid A;

(2) heating the cocoa butter liquid A to about 33 ℃ while stirring, then placing the cocoa butter liquid A into a constant temperature device with the temperature set to 20 ℃ for standing for 8 minutes, and filtering and collecting the liquid to obtain cocoa butter liquid B;

(3) placing the cocoa butter liquid B in a constant temperature device with the temperature set at 16 ℃, continuously stirring for about 8 minutes, and filtering and collecting the liquid to obtain cocoa butter liquid C;

(4) placing the cocoa butter liquid C in a sealed mixing tank, then conveying negative oxygen ions generated by a negative oxygen ion generating device into the mixing tank through a sealed pipeline, mixing the negative oxygen ions with the cocoa butter liquid C, and stopping conveying the negative oxygen ions when the temperature of the mixing tank is firstly increased and then is reduced to be consistent with or basically consistent with the ambient temperature, namely when the mixing of the negative oxygen ions and the cocoa butter liquid C reaches a saturated state, so as to obtain the content of the oxygen capsule;

(5) filling the content of the oxygen capsule into a pharmaceutical-grade gelatin capsule shell to obtain the oxygen capsule.

EXAMPLE 3 preparation of oxygen capsules

The method comprises the following steps:

(1) heating deodorized cacao butter to about 70 deg.C, continuously stirring to melt deodorized cacao butter, cooling to about 26 deg.C, standing in a constant temperature device at 25 deg.C for about 7 min, filtering, and collecting liquid to obtain cacao butter liquid A;

(2) heating the cocoa butter liquid A to about 30 ℃ while stirring, then placing the cocoa butter liquid A into a constant temperature device with the temperature set to 20 ℃ for standing for 8 minutes, and filtering and collecting the liquid to obtain cocoa butter liquid B;

(3) placing the cocoa butter liquid B in a constant temperature device with the temperature set at 15 ℃, continuously stirring for about 8 minutes, and filtering and collecting the liquid to obtain cocoa butter liquid C;

(4) placing the cocoa butter liquid C in a sealed mixing tank, then conveying negative oxygen ions generated by a negative oxygen ion generating device into the mixing tank through a sealed pipeline, mixing the negative oxygen ions with the cocoa butter liquid C, and stopping conveying the negative oxygen ions when the temperature of the mixing tank is firstly increased and then is reduced to be consistent with or basically consistent with the ambient temperature, namely when the mixing of the negative oxygen ions and the cocoa butter liquid C reaches a saturated state, so as to obtain the content of the oxygen capsule;

(5) filling the content of the oxygen capsule into a pharmaceutical-grade gelatin capsule shell to obtain the oxygen capsule.

Detection of oxygen-enriched capsule components

The contents of the oxygen capsule prepared in example 2 according to the present invention were sent to a national detection technology service (Guangzhou) GmbH for component detection. During the detection process, when the content of the oxygen capsule is tried to be dried under an infrared lamp, the oxygen capsule content sample smokes, thereby also proving that the content of the oxygen capsule contains oxygen ions and the state of the oxygen ions is unstable, and the oxygen ions are released after heating to cause the oxygen capsule content sample to burn at high temperature.

The oxygen capsule content is detected by the original oxygen capsule content, and an infrared spectrogram, a thermal cracking gas chromatography-mass spectrometry (Py-GC/MS) total ion flow diagram, a nuclear magnetic resonance hydrogen spectrogram and a nuclear magnetic resonance carbon spectrogram of the oxygen capsule content are shown in fig. 1-4 in sequence. According to the analysis of the map, the content of the oxygen capsule provided by the invention mainly comprises the following components: fatty acid glyceride, fatty acid isopropyl ester, fatty acid, fatty aldehyde and fatty acid glycidyl ester.

Since the oxygen ion state in the contents of the oxygen capsule is unstable and cannot be detected alone, only the oxygen content of the contents of the oxygen capsule is detected. Through detection, the oxygen content of the oxygen capsule provided by the invention is 24.268%. The contents of the oxygen capsule may also contain some intermediates that are unstable in nature, but cannot be accurately isolated and identified because they readily polymerize into polymers under the conditions of detection.

Second, the typical case of using the oxygen capsule of the invention to treat or assist in treating diseases

Case one, hypertension

Zhao women, 79 years old, fixed in Guangzhou. The history of hypertension is 10 years. Before the oxygen capsule is taken, the blood pressure is generally 140-160/110. If the dosage is higher than 140 before bedtime, the next morning a tablet of valsartan needs to be taken when getting up. The oxygen capsule of the invention is taken at 12 months in 2018, the blood pressure before sleep is no more than 140 after 1 month, and valsartan is not taken from that time. At present, the blood pressure is generally 120-140/80 at ordinary times.

Case two, hypertension

Mr. Wang, 59 years old, colonized in Beijing. The history of hypertension is 7 years. Before the oxygen capsule is taken, the blood pressure is generally 140-150/90, and the hypotensive drug is taken every morning. The oxygen capsule is orally taken at the end of 5 months in 2021, with two capsules on empty stomach every day. The administration of hypotensor is stopped at the end of 6 months in 2021. Blood pressure is currently generally maintained at 115/80. One week after oral administration of oxygen capsule, morning bobs occur every day.

Case three, gout

Mr. Wedner, age 47, established in Guangzhou, had a 5-year history of gout. Before the oxygen capsule of the invention is taken, the blood uric acid is 630, the oxygen capsule is taken in 2019, and the blood uric acid is reduced to 522 after three months. After that, no medical treatment is taken, and the blood uric acid is found to be reduced to 347 by medical examination in 2020; physical examination took place at 7 months in 2021, and blood uric acid remained at 279. Basically indicates that gout is radically cured.

Case four, gout

Mr. Wang, age 46, established in Beijing, had a 2-year history of gout. Before the oxygen capsule of the invention is taken, the blood uric acid 441 is taken at 6 months in 2021, no other medicine is taken in the period, the blood uric acid is detected at the bottom of 8 months in 2021, the blood uric acid is reduced to 411, and the normal range is entered.

Case five, prostatitis, senile dementia

Mr. Li, 86 years old, colonized the Shanghai, with chronic prostatitis and senile dementia. The prostatitis is serious, and the urinary catheter is required to be inserted to urinate. The oral administration and anal oxygen-filled capsule begin in 2018 in 9 months, the inflammation of the body disappears after 3 months, and after 7 months, doctors can pull out the urinary catheter without affecting urination through color ultrasound. The color ultrasound data before and 7 months after taking the oxygen capsule are shown in the following table 1:

TABLE 1

Transverse diameter	4.6cm	4.3cm
			Upper and lower diameter	3.8cm	3.7cm
Front and back diameter	3.5cm	3.0cm
			Size of internal gland	2.9×2.2cm	2.8×2.0cm

The oxygen capsule can be taken to improve senile dementia of Mr. plum. Before taking the oxygen capsule, Mr. Li has little knowledge about her daughter and can not control her to spit things in mouth outwards, and can spit things out everywhere as long as she wants to spit things in mouth. After 5 months of taking the oxygen capsule, the plum is gradually conscious and does not spit everywhere. After 6 months, the girls began to be concerned about wearing warm clothes and were asked to not be too tiring. After 9 months, the patients were identified as non-senile dementia in admission tests (safety consciousness test and vegetable classification test) in the nursing home.

Case six, anxiety disorder

Mr. Sun, 60 years old, colonized North America, golf coach. The history of anxiety disorder is 5 years, and the user needs to take two hypnotics to sleep normally. Students need to eat up to 4 grains to fall asleep during the competition. The symptoms of stomach discomfort, dizziness, dysphoria and the like can appear under slight pressure. The first time in 2 months in 2019, two oxygen capsules are taken, and even though 2 hypnotics are taken in the evening, the sleep quality is obviously improved, and people feel energetic the next day. After one month, hypnotics are discontinued completely at the rate of an average half-pill reduction per week. Until 4 months and so far in 2019, one oxygen capsule is taken every day, and no hypnotic is taken. Even if the pressure before the race is applied, symptoms such as stomach discomfort, dizziness, dysphoria and the like do not appear any more.

Seventh, systemic lupus erythematosus

Dian women, age 52, stationed in North America, a home care service provider. Three decades ago, the patient is diagnosed with systemic lupus erythematosus, and the blood examination shows that white blood cells, platelets and lymphocytes are all greatly lower than the normal range. Can not be cured by receiving various medical treatment methods (comprising hormone medicine and traditional Chinese medicine). When hormone medicines are taken, due to the large side effect, the medicines are allergic to light and easy to fatigue, fever is generated almost every day, and people need to sleep for one or two hours every noon or are tired very late in the afternoon and at night. Oxygen capsules were started in 2018. Before taking the oxygen capsule (6 months and 5 days in 2017), blood examination is carried out in the United states, and the results of several systemic lupus erythematosus-related blood phase indexes are shown in Table 2:

TABLE 2

Examination item	Results	Normal range
			White blood cell WBC	2.1	4.5-10.8
Platelet PLT	101	130-400
			Lymphocyte LYM #	0.5	1.2-3.4

After the oxygen capsule is taken for half a year, the patient does not have fever, does not sleep in the daytime at all, and is full of energy all day long. The results of several systematic lupus erythematosus-associated blood phase indicators examined at the first subsidiary hospital of the university of zhongshan, guangzhou, china, for more than two years of administration are shown in table 3:

TABLE 3

Examination item	Results	Normal range
			White blood cell WBC	3.21	4-10
Platelet PLT	125	100-300
			Lymphocyte LYM #	1.0	1.0-3.3

In which the white blood cells are nearly normal and the platelets and lymphocytes are already normal.

Case eight, gastric ulcer

Mr. Lin, age 29, settled in the Guangdong, history of gastric ulcer 6 years, must eat food on schedule, no food at that point, and has intolerable gastric colic. The oxygen capsule is taken at 3 months in 2020 for 20 days, two capsules are taken every day, no other medicine is taken in the period, after the hospital examination, the wound of the gastric ulcer is healed, and no stomachache occurs.

What has been described above are merely some embodiments of the present invention. It will be apparent to those skilled in the art that various changes and modifications can be made without departing from the inventive concept thereof, and these changes and modifications can be made without departing from the spirit and scope of the invention.